share_log

美股异动|再鼎医药涨超5% 原先声药业副总裁将加入公司任大中华区首席商务官

Changes in US stocks | Zaiding Pharmaceutical rose more than 5%, and the former vice president of Xiansheng Pharmaceutical will join the company as the chief commercial officer in Greater China

Gelonghui Finance ·  Apr 24 22:16
On April 24, Gelonghui | Zaiding Pharmaceutical (ZLAB.US) rose more than 5% to $15.88. On April 22, Zhu Tong, the former vice president of Xiansheng Pharmaceutical, joined Zaiding Pharmaceutical as the Chief Commercial Officer of Greater China. Liang Yi, the current Chief Commercial Officer and President of Greater China, will leave office on April 30. Zaiding Pharmaceutical has confirmed the news to the media. According to data, Zhu Tong has extensive experience in pharmaceutical marketing and has worked for well-known multinational pharmaceutical companies such as AstraZeneca, Roche, and Sanofi.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment